Picture two people, both three months into a GLP-1 medication (with names like Ozempic, Mounjaro, Wegovy, etc.), both losing weight, both telling you the food noise in their head has finally gone silent.
One of them describes it like waking up from a fog they didn’t know they were in. Meals stopped being a constant mental negotiation. They have space in their head they’ve never had before.
The other describes it more like the volume got turned down on their whole life, not just the food part. They’re not thinking about food anymore, technically true. But they’re also not thinking about much else. The hobby that used to light them up doesn’t quite land the same way. Nothing is wrong, exactly. Nothing feels particularly right either.
From the outside, they look like the same success story. Two people, less food noise, less weight, generally calmer. As a psychotherapist who works with a lot of autistic and ADHD adults, I’ve come to believe these might not be the same story at all, and I don’t think enough people are asking the question that would tell them apart.
I’m not a prescriber, and I’m not writing this to weigh in on drug mechanism or pharmacology. What I am positioned to notice, session after session, is what happens to behavior, regulation, and emotional functioning once appetite quiets down. That’s the part of this conversation that deserves more attention than it currently gets.
For readers less familiar with the terminology, GLP-1 medications were originally developed for diabetes and are now widely prescribed for weight loss. Many people describe their effect using the phrase “food noise,” meaning the near-constant background mental chatter about food, cravings, and eating that some people experience throughout the day. These medications tend to quiet that chatter substantially. For a lot of people, that quiet feels like enormous relief.
Layering a medication that alters appetite onto a nervous system that already struggles to read its own internal signals isn’t automatically harmful. It also isn’t automatically neutral. I think it deserves more clinical attention than “appetite suppression” as a category tends to get.
For neurocomplex adults specifically, where autistic sensory patterns and ADHD reward-seeking coexist in the same nervous system, this can get genuinely complicated.

Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.